Reports Q3 revenue $6.1B, consensus $6.04B. “We delivered another quarter of strong sales and double-digit adjusted earnings per share growth,” said Kevin Lobo, Chair and CEO. “Our teams continue to execute at a high level, driving performance at the high-end of MedTech and building sustained momentum across our broad portfolio.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK: